Search

  • Contact Us
  • Quick Order

Ion Torrent Rapid Next-Generation Sequencing (NGS)

Ion Torrent NGS solutions enable laboratories worldwide to generate NGS biomarker test results in-house in as little as 24 hours. 

Rapid, easy, and automated Ion Torrent next-generation sequencing solutions support the end-to-end workflow—sample to report—making in-house NGS testing more accessible to more labs globally.

Featured Ion Torrent NGS platforms

Ion Torrent Genexus System

Through a combination of workflow automation, sequencing performance, and automated data analysis and reporting, the Ion Torrent Genexus System can bring the power of rapid NGS to virtually any lab without the need for extensive sequencing or bioinformatics expertise.

Ion GeneStudio S5 Systems

Helping researchers achieve deeper insights through fast, efficient, and cost-effective generation of large sequencing datasets, the Ion GeneStudio S5 Systems enable scalable NGS for a broad range of applications.

Explore all NGS instruments for clinical research

Thermo Fisher Scientific's Ion Torrent NGS platforms for clinical research offer flexible, fast, and easy-to-use solutions that enable laboratories worldwide to bring rapid NGS testing in-house.

Featured Ion Torrent NGS applications

Cancer research

Explore our complete Oncomine portfolio of end-to-end next-generation sequencing (NGS) solutions to detect relevant biomarkers in oncology with exceptional speed and accuracy to advance precision oncology research globally.

Reproductive health research

Our solutions for NGS-based expanded carrier screening (ECS) research and preimplantation genetic testing (PGT) offer critical insights that may increase probability of success for future pregnancies and healthier future generations.

Infectious disease and microbiology research

The Ion Torrent and Ion AmpliSeq NGS technologies offer multiple solutions with advantages for clinical researchers studying infectious diseases and other microbial application areas to facilitate rapid and accurate sequencing of microbes.

Inherited disease research

From targeted gene panels to exomes for inherited disease research, our NGS solutions help clinical researchers discover causal variants easily with the simple and rapid Ion Torrent sequencing workflow.

Custom Ion AmpliSeq targeted NGS panels

When navigating through the complexities of NGS testing in clinical research applications, you need a solution that is both flexible and rapid for analyzing variants and regions of interest. Ion AmpliSeq technology can help. It is globally used as an amplicon-based enrichment method for targeted NGS. Clinical researchers worldwide choose Ion AmpliSeq technology for fast, simple, and scalable NGS solutions.

 

Contact an NGS sales specialist to learn more about Ion AmpliSeq panels for clinical research.

How does Ion Torrent NGS work?

Ion Torrent NGS exploits the fact that addition of a dNTP to a DNA polymer releases a hydrogen ion. We measure the pH change resulting from those hydrogen ions using semiconductors, simultaneously measuring millions of such changes to determine the sequence of each fragment.

 

The semiconductor approach—unlike optics or modified nucleotides used in other NGS technologies—helps you implement a fast and simple workflow that can scale according to your clinical research needs across multiple applications including oncology, reproductive health, infectious disease, inherited disease, and more. 

 

Our targeted sequencing approach introduces a PCR-based sequence enrichment step using Ion AmpliSeq technology that focuses on genes or even genetic variants of interest; a good example is the targeting of oncogenes and tumor suppressors in a cancer research study.

Featured Ion Torrent NGS resources

Keep learning about next-generation sequencing, and how easy it is to bring rapid NGS testing in-house with Ion Torrent instruments and products.

Brochure: The Genexus System

Brochure: Targeted NGS Applications

Ebook: Introduction to NGS

For Research Use Only. Not for use in diagnostic procedures.

PMR-002663